跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,689 条关于
“IgA”
全部
3,689
临床试验
2,664
药物
421
机构
25
资讯
579
9天前
FDA Clears IND for Alebund's First-in-Class IgA Protease AP308 in IgA Nephropathy
去年
Felzartamab Shows Promise in Reducing Proteinuria in IgA Nephropathy Patients
4年前
Phase II Study Shows Atacicept's Potential in Treating IgA Nephropathy
去年
Otsuka Submits BLA for Sibeprenlimab: A Novel Targeted Therapy for IgA Nephropathy
去年
Paradigm Shift in IgA Nephropathy Treatment: Novel Targeted Therapies Address Disease Mechanisms
去年
Zigakibart Shows Sustained 60% Proteinuria Reduction in 100-Week IgA Nephropathy Study
3年前
Targeting the Endothelin A Receptor in IgA Nephropathy: A New Therapeutic Approach
10个月前
Sibeprenlimab Demonstrates 54% Proteinuria Reduction in Largest Phase 3 IgA Nephropathy Trial
5个月前
Calliditas Therapeutics Presents New NefIgArd Trial Data Supporting Nefecon's Gut-Targeted Mechanism in IgA Nephropathy
去年
IgA Nephropathy Pipeline Shows Strong Growth with 30+ Therapies in Development Across Multiple Clinical Stages
第 1 页,共 58 页
上一页
下一页